Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Pharmaceutical strategy

How Poor Branding Hurts Pharma Product Launches
Posted in
  • Strategy & Execution

How Poor Branding Hurts Pharma Product Launches

In the United States pharmaceutical market, a product launch is one of the most financially and … How Poor Branding Hurts Pharma Product LaunchesRead more

by Jayshree Gondane•February 25, 2026February 25, 2026•0
Why Clinical Trial Data Fails to Translate Into Market Success
Posted in
  • Industry Landscape
  • Strategy & Execution

Why Clinical Trial Data Fails to Translate Into Market Success

A therapy can clear Phase III, secure FDA approval, and generate headline optimism-only to miss revenue … Why Clinical Trial Data Fails to Translate Into Market SuccessRead more

by Jayshree Gondane•February 15, 2026February 15, 2026•0

Recent Posts

  • The Hidden Compliance Risk of AI in Pharmaceutical Promotion
  • The Truth About Drug Price Transparency Laws and Pharmaceutical Marketing Strategy
  • FDA Draft Guidance on AI in Pharmaceutical Advertising: What Pharma Marketers Must Know Now
  • The Uncomfortable Truth About Pharmaceutical Marketing Failure
  • The Truth About Pharmaceutical Marketing in the United States

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A